Published March 8, 2018 This content is archived.
The University at Buffalo’s Clinical and Translational Science Institute (CTSI), with local institutional support and an award from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, has awarded 11 new grants to support promising translational research projects in Western New York.
Recipients of the 2018-19 CTSI Translational Science Pilot Studies Program awards are:
The pilot studies program provides seed money to help advance promising new technologies and therapeutics from the conceptual stage to clinical studies. Having preliminary, proof-of-concept studies in hand greatly enhances a proposal’s chance of attracting outside funding for further testing.
Funding for the CTSI Translational Science Pilot Studies Program is provided by: UB’s Office of the Provost, Office of the Vice President for Research and Economic Development and Office of the Vice President for Health Sciences, Roswell Park Comprehensive Cancer Center and the deans of UB’s Jacobs School of Medicine and Biomedical Sciences, School of Dental Medicine, School of Pharmacy and Pharmaceutical Sciences, School of Engineering and Applied Sciences, School of Public Health and Health Professions and School of Nursing. Increased funding from the NIH Clinical and Translational Science Award has expanded the number of pilot study awards in recent years.
“In addition to supporting innovative, high-impact, clinical-translational science, the program looks for projects that foster cross-disciplinary collaborations and mentoring relationships,” said Steven J. Fliesler, PhD, UB Distinguished Professor in the Department of Ophthalmology and co-director of the Translational Pilot Studies program. “Priority is given to projects that address health care disparities in underserved populations in Western New York and allow applicants to generate sufficient preliminary data to secure future extramural funding.”
Brahm Segal, MD, Chief of Infectious Diseases at Roswell Park Comprehensive Cancer Institute and a member of UB’s Department of Medicine, is the program’s other co-director.
Investigators who received CTSI pilot study awards in 2016-17 will present their findings at a colloquium to be held in the Clinical and Translational Research Center in October.
The Request for Applications (RFA) for the 2019-2020 round of studies is scheduled to be released in the summer of 2018. More information will be posted to the CTSI Pilot Translational Studies Program webpage as it becomes available.
The research is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo.
Ellen Goldbaum
Senior Medical Editor
Office of University Communications
(716) 645-4605